About Accriva Diagnostics
Accriva Diagnostics is a company based in San Diego (United States) founded in 2009 was acquired by Instrumentation Laboratory in January 2017. Accriva Diagnostics has raised $216.01 million across 6 funding rounds from investors including Kleiner Perkins, Werfen and Warburg Pincus. The company has 399 employees as of December 31, 2017. Accriva Diagnostics has completed 1 acquisition, including Accumetrics. Accriva Diagnostics operates in a competitive market with competitors including Diagnostica Stago, Entegrion, Enzyre, MedicQuant ApS and Perosphere, among others.
- Headquarter San Diego, United States
- Employees 399 as on 31 Dec, 2017
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$216.01 M (USD)
in 6 rounds
-
Latest Funding Round
$15.47 M (USD), Private Equity Round
Mar 10, 2015
-
Investors
Kleiner Perkins
& 5 more
-
Employee Count
399
as on Dec 31, 2017
- Investments & Acquisitions
-
Acquired by
Instrumentation Laboratory
(Jan 01, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Accriva Diagnostics
Accriva Diagnostics has successfully raised a total of $216.01M across 6 strategic funding rounds. The most recent funding activity was a Private Equity Round of $15.47 million completed in March 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Accriva Diagnostics
Accriva Diagnostics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Kleiner Perkins, Werfen and Warburg Pincus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stage-agnostic investments in US life-sciences sectors are managed.
|
Locked | Locked | Locked | |
|
Multi-stage private equity investments are pursued across diverse sectors.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in early-stage tech startups
|
Locked | Locked | Locked |
Investor details for Accriva Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Accriva Diagnostics
Accriva Diagnostics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Accumetrics.
Investment portfolio details for Accriva Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Platelet function assays and coagulation systems are developed and marketed.
|
Locked | Locked | 1996 | Locked |
Complete acquisition details for Accriva Diagnostics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Accriva Diagnostics
Detailed financials for Accriva Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Accriva Diagnostics Comparisons
Peer comparison for Accriva Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Accriva Diagnostics
Accriva Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Diagnostica Stago, Entegrion, Enzyre, MedicQuant ApS and Perosphere, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A portfolio of hemostasis and coagulation diagnostic products is manufactured.
|
|
| Locked | Locked | Locked |
Hemostasis and fluid replacement products are provided for medical applications.
|
|
| Locked | Locked | Locked |
Smart diagnostics devices for blood coagulation analysis are developed.
|
|
| Locked | Locked | Locked |
Diagnostic kits for blood anticoagulant detection are provided.
|
|
| Locked | Locked | Locked |
Anticoagulant reversal agent and small molecules to prevent allergic reactions, traumatic brain injury.
|
Detailed competitors of Accriva Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Accriva Diagnostics
Complete news archive for Accriva Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Accriva Diagnostics
Accriva Diagnostics was founded in 2009.
Accriva Diagnostics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Accriva Diagnostics is a funded company, having raised a total of $216.01M across 6 funding rounds to date.
As of Dec 31, 2017, the latest employee count at Accriva Diagnostics is 399.
Accriva Diagnostics was founded in 2009 and is headquartered in San Diego, United States. Operations focus on the medical diagnostics sector, where near-patient testing systems are developed and commercialized. Products include a compact microcoagulation monitoring system with tests such as ACT, PT, and APTT; whole blood coagulation analyzers; heel and finger incision devices for newborns and general use; the Avoximeter 1000E oximeter; and antiplatelet reactivity testing devices.
Accriva Diagnostics's top competitors include Diagnostica Stago, MedicQuant ApS and Enzyre.
Accriva Diagnostics has made 1 acquisition, including Accumetrics.
Accriva Diagnostics has 6 investors. Key investors include Kleiner Perkins, Werfen, Warburg Pincus, Instrumentation Laboratory, and Blackrockbkcc.